I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| acinar cell | 4 studies | 61% ± 28% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| acinar cell | 4 studies | 61% ± 28% |
Insufficient scRNA-seq data for expression of CLPS at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 1030232.88 | 328 / 328 | 67% | 2580.06 | 120 / 178 |
| ovary | 67% | 100.85 | 120 / 180 | 25% | 13.81 | 107 / 430 |
| stomach | 76% | 200.78 | 273 / 359 | 11% | 83.29 | 31 / 286 |
| breast | 44% | 294.81 | 203 / 459 | 42% | 1.74 | 474 / 1118 |
| spleen | 76% | 123.49 | 183 / 241 | 0% | 0 | 0 / 0 |
| uterus | 63% | 77.95 | 107 / 170 | 12% | 0.31 | 57 / 459 |
| adrenal gland | 70% | 93.07 | 181 / 258 | 0% | 0.01 | 1 / 230 |
| esophagus | 54% | 122.28 | 779 / 1445 | 15% | 0.57 | 28 / 183 |
| liver | 67% | 132.98 | 151 / 226 | 2% | 16.34 | 9 / 406 |
| intestine | 52% | 104.28 | 501 / 966 | 9% | 42.90 | 50 / 527 |
| kidney | 56% | 74.35 | 50 / 89 | 1% | 0.03 | 12 / 901 |
| prostate | 57% | 114.15 | 139 / 245 | 1% | 0.02 | 3 / 502 |
| bladder | 52% | 46.57 | 11 / 21 | 4% | 0.09 | 21 / 504 |
| lung | 44% | 62.56 | 252 / 578 | 8% | 0.33 | 93 / 1155 |
| thymus | 44% | 65.96 | 286 / 653 | 0% | 0.05 | 2 / 605 |
| blood vessel | 44% | 195.46 | 584 / 1335 | 0% | 0 | 0 / 0 |
| skin | 40% | 101.29 | 727 / 1809 | 1% | 0.04 | 7 / 472 |
| adipose | 41% | 390.62 | 491 / 1204 | 0% | 0 | 0 / 0 |
| heart | 38% | 87.25 | 327 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 38% | 48.64 | 349 / 929 | 0% | 0 | 0 / 0 |
| brain | 32% | 45.12 | 842 / 2642 | 1% | 0.01 | 7 / 705 |
| muscle | 33% | 49.24 | 262 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 9% | 0.20 | 4 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 7% | 0.09 | 2 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0032094 | Biological process | response to food |
| GO_0006629 | Biological process | lipid metabolic process |
| GO_0007586 | Biological process | digestion |
| GO_0016042 | Biological process | lipid catabolic process |
| GO_0009617 | Biological process | response to bacterium |
| GO_0005576 | Cellular component | extracellular region |
| GO_0008047 | Molecular function | enzyme activator activity |
| GO_0035473 | Molecular function | lipase binding |
| Gene name | CLPS |
| Protein name | Pancreatic colipase preproprotein isoform 1 Colipase |
| Synonyms | hCG_15776 |
| Description | FUNCTION: Colipase is a cofactor of pancreatic lipase. It allows the lipase to anchor itself to the lipid-water interface. Without colipase the enzyme is washed off by bile salts, which have an inhibitory effect on the lipase. .; FUNCTION: Enterostatin has a biological activity as a satiety signal. . FUNCTION: Colipase is a cofactor of pancreatic lipase. It allows the lipase to anchor itself to the lipid-water interface. Without colipase the enzyme is washed off by bile salts, which have an inhibitory effect on the lipase. .; FUNCTION: Enterostatin has a biological activity as a satiety signal. . |
| Accessions | ENST00000616014.3 ENST00000259938.7 Q5U808 A0A087X0Q7 P04118 ENST00000622413.2 A0A087WZW1 |
